Tracking quality of life in advanced neuroendocrine tumors
Part of Cancer clinical trials.
This study follows people with advanced neuroendocrine tumors (NETs) that cannot be removed by surgery or have spread. Its goal is to see how long patients can live without having serious side effects from treatment, so doctors can better understand which treatments are worth the risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a neuroendocrine tumor that cannot be fully removed by surgery or has spread, and you have not had any treatment for it before (except for somatostatin analogs or surgery at first).
- You have been diagnosed with this type of advanced NET within the last 6 months.
- Your tumor is a well-differentiated neuroendocrine tumor, as confirmed by a pathologist.
- You do not have any medical reasons that would make it unsafe to start standard treatments.
- You are being followed at a specialist center in France that is part of the ENDOCAN network.
- You are 18 years old or older and agree to have your data collected for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people after surgery to remove neuroendocrine tumors (NETs) from the stomach, intestines, or pancreas. It aims to understand long-term outcomes and quality of life.
This study looks at how well patients with neuroendocrine tumors handle oral cancer pills and how those pills affect their quality of life. The goal is to improve support and education for people taking these medications at home.
This study follows patients over time to see how anticancer treatments affect their quality of life. It's for adults who receive special cancer drugs and also get other support at the Rafael Institute.
This study looks at long-term health problems and quality of life in people who survived germ cell tumors after strong chemotherapy with a stem cell transplant or other standard treatments. It may help doctors understand which late side effects are most common and how to better support survivors.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This study looks at how internal radiation therapy (RIV) affects quality of life in people with neuroendocrine tumors. It aims to understand how well patients tolerate this treatment and how it impacts daily life.
Hear when a new Neuroendocrine (NE) Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.